NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Low side effects, orphan indication, and strong indications of efficacy for both nGBM and rGBM validating each other and potentially the mechanism of action which likely is also validated by other data the company likely has including biomarkers, some of which we know, some we may not yet know.

I think the notions some promote, that it can’t suffice is very dubious and unlikely to prevail.